Larry S. Schlesinger

Larry S. Schlesinger's Title

Larry S. Schlesinger serves as the President and Chief Executive Officer of Texas Biomedical Research Institute (Texas Biomed). In this role, he has been instrumental in steering the institute towards groundbreaking scientific discoveries and fostering innovative partnerships with leading biomedical organizations.

Larry S. Schlesinger's Education and Expertise

Larry S. Schlesinger earned his BA in Biology from Cornell University and his MD from Rutgers Medical School. Following this, he completed his residency in Internal Medicine at the University of Michigan and clinical and research fellowships in Infectious Diseases at UCLA. His extensive education laid the foundation for his expertise in infectious diseases, particularly tuberculosis and lung biology, making him an internationally recognized authority in these fields.

Larry S. Schlesinger's Achievements

Larry S. Schlesinger has a remarkable list of achievements, including being named a Healthcare Hero by the San Antonio Business Journal in 2018 for his outstanding medical research. He has authored over 200 peer-reviewed articles, reviews, and chapters in textbooks, and edited two books. His research has been continuously funded by the NIH and other agencies for 30 years, underscoring his significant contributions to the field. Additionally, he is a Fellow of the AAAS, American Academy of Microbiology, AAP, and IDSA.

Larry S. Schlesinger's Background

Larry S. Schlesinger's career began at the University of Iowa in 1991, where he served as Fellowship Director for the Division of Infectious Diseases and Associate Chair of the Department of Medicine. He later moved to Ohio State University in 2002, where he became the Director of the Division of Infectious Diseases and the first Chair of Microbial Infection & Immunity. He founded the university-wide Center for Microbial Interface Biology, now known as the Infectious Diseases Research Institute.

Larry S. Schlesinger's Company

Since 2017, Larry S. Schlesinger has led Texas Biomedical Research Institute (Texas Biomed) as its President and CEO. Under his leadership, Texas Biomed has undergone a transformational strategic planning process, strengthening relationships with regional institutions like UT Health San Antonio and the Southwest Research Institute. His efforts have significantly advanced Texas Biomed's mission to pioneer and innovate in the biomedical landscape.